By analyzing microRNAs in blood, saliva and vaginal mucus, researchers have uncovered fluid-specific molecular patterns that may aid in future non-invasive diagnosis of endometriosis.

study: Identification of candidate microRNA biomarkers for endometriosis in various body fluids. Image credit: Krakenimages.com/Shutterstock.com

Recently published pilot paper scientific report Investigate potential microRNA changes in body fluids that may serve as molecular markers for endometriosis. This finding will contribute to the development of tools for timely diagnosis and intervention.

Why circulating microRNAs are promising diagnostic candidates

Endometriosis is a chronic disease that occurs in up to 10% of women of reproductive age. It is associated with pelvic pain, infertility, and pelvic masses, but may not cause symptoms. Diagnosis is based on the patient’s history of symptoms, physical examination, and imaging studies.

Unfortunately, these are far from reliable methods in providing a definitive diagnosis. Because most women are diagnosed only after laparoscopy (diagnostic keyhole surgery), endometriosis is usually diagnosed only 5 to 12 years after the first symptoms appear and after the patient has seen multiple doctors.

Endometriosis is caused by estrogen and progresses in the presence of estrogen.

microRNA (miRNAs) are fragments of RNA molecules that act on transcribed RNA to regulate the levels of specific genes. These are associated with a variety of diseases, including cancer, infections, and autoimmune diseases. They resist rapid deterioration. Therefore, in the current study, we attempted to identify and measure them in serum, saliva, and vaginal mucus. The aim was to use next-generation sequencing to compare the levels of these factors in body fluids of women with endometriosis and controls.

Early modeling research using artificial intelligence (A.I.) was based on 109 saliva miRNAs.The area under the curve was over 95%, showing excellent sensitivity and specificity, and high discriminatory ability. However, it is not yet ready for routine clinical use for multiple reasons.

• it’s massive miRNA Panels are expensive and require advanced equipment, especially for next-generation sequencing
• Does not use multiple body fluids, which limits effectiveness and reproducibility
• drains vaginal mucus miRNA and proteomic profiling
• Rapid fluctuations in hormones occur during the menstrual cycle and can affect the level of circulating blood volume. miRNAs

The current study used three conveniently collected body fluids: saliva, serum, and vaginal mucus. miRNA Profiling combined with serum proteomics. This is claimed to be the first prospectively recruited, exploratory cross-sectional study incorporating all three sources to uncover molecular changes in endometriosis.

After identifying miRNABecause there were differences in expression between patients and controls, the researchers further analyzed them to identify target genes. These genes helped determine which parts of a cell’s functions and components are involved. miRNA-Regulatory changes in intermediaries. keg Pathway analysis helped identify biological pathways that are overrepresented in endometriosis patients.

Serum proteomics was performed to understand cell-cell network interactions. miRNAand the proteins produced by the affected genes.

Distinctive microRNA signatures appear throughout serum, saliva, and mucus

The study included 20 participants: 10 patients with endometriosis (stages III and IV of the aSRM classification, indicating moderate to advanced disease) and 10 teratoma controls, all of whom had ovarian teratomas. of CA125 Compared to one in the control group, the former had higher markers and most had dysmenorrhea.

The results clearly showed fluid-specific patterns. miRNA expression. serum miRNA was the most abundant and saliva was the least abundant, and this distribution pattern is consistent with previous studies, although this study itself identified distinct body fluid-specific differences. miRNA signature.

Serum content 13 miRNAIt was expressed at significantly different levels in women with endometriosis compared to controls. In contrast, saliva and vaginal mucus showed 3 and 6, respectively.

abundant amount miRNAs in serum was consistent with previous studies.

The total number of expressions and the number of differential expressions are small. miRNAs in saliva is in contrast to previous studies. This may be due to differences in sample size, disease phenotype, and technical differences. Inherent differences between saliva and other body fluids may also play a role. saliva miRNAUltimately, it may become a complementary rather than a primary biomarker for endometriosis.

Nothing is differentially expressed miRNAAlthough miR-1304-3p was common to all body fluids, miR-1304-3p was differentially expressed in serum and mucus, but it was detected in less than half of the cases. of miRNA Expression profiles can be sample type specific. This is probably miRNA Interorganizational origins and functions.

Researchers found that menstrual period had a limited overall effect. miRNA expression, but serum has two miRNAshowed a major change.

Analysis of the predicted target genes showed that they were altered. miRNA The expression was associated with multiple pathways including apoptosis, Wnt signaling, autophagy, and cellular senescence. This reflects a common disease process, despite the different biological properties of each body fluid.

We performed serum proteomics because it had the highest proteomics. miRNA Abundant. This led to the identification of 59 upregulated serum proteins predicted to be differentially expressed targets. miRNAs.These were caused by dysregulation miRNAs, potentially important signals miRNAcombination of target genes in endometriosis.

Among these, miR-200a-3p and miR-200b-3p showed moderate discriminatory ability and may be useful as candidates for non-invasive serum markers of endometriosis.

Despite these findings, this study has several limitations to generalizability. These include:

• Pilot nature with small sample size
• No external validation by comparison within the group or with a larger, more diverse group
• Only patients with moderate to advanced endometriosis were included
• Only controls with ovarian teratomas were included
• Lack of understanding of lifestyle factors that may influence miRNA expression
• The cross-sectional nature precluded the ability to track change. miRNA Expression over time or with intervention

The important thing is that miRNA Expression was not compared to molecular changes at the lesion level. This could mean dysregulation. miRNA Profile reflects systemic inflammation or general changes in tissue or organ function secondary to endometriosis rather than a lesion-specific pattern.

Further experimental studies are essential to detect the association and mechanistic pathways between endometriotic lesions and endometriotic changes. miRNA expression.

Promises and limitations of non-invasive microRNA profiling

This prospectively recruited cross-sectional pilot study provided identification and comparisons. miRNA Expression profiles in three body fluids show fluid-specific patterns. Contains vaginal mucus miRNA This is a common and easily available sample type, so profiling it for the first time is important. miRNA biomarker identification.

Two markers were identified as potential discriminators of endometriosis, but the small sample size and lack of external validation make future validation essential. However, this work adds the following knowledge: miRNAIt’s endometriosis. Multisampling and multiomics may help facilitate the development of improved diagnostics and treatments in this complex and difficult condition.

Download your PDF copy now.